Inventiva Pharma Alternatives & Competitors
12 companies similar to Inventiva Pharma — A clinical-stage biopharmaceutical company focused on the development of oral sm...
Companies similar to Inventiva Pharma
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
Loos, France
Sling Therapeutics
Focused on late-stage development of an oral small molecule for the treatment of thyroid e...
Ann Arbor, United States
VRise Therapeutics, Inc.
A Precision Oncology Company
Cambridge, United States
Ansun Biopharma, Inc.
Discovering solutions for the world
San Diego, United States
Rival Readout
Competing with Inventiva Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Response Pharmaceuticals
A Clinical Stage (Phase 2) biopharmaceutical company developing treatments for weight mana...
Crestone Pharma
Crestone is a clinical-stage company focused on developing small molecule drugs for seriou...
Boulder, United States
Neurolixis
New treatments for central nervous system disorders
Park Ridge, United States
Kinnate Biopharma Inc.
Inspiring Hope to Those Battling Cancer
San Diego, United States
OrsoBio
Advancing first-in-class therapies to restore energy homeostasis
Palo Alto, United States
Kestrel Therapeutics
We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...
Watertown, United States
Antios Therapeutics
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing th...
Atlanta, United States
SELLAS Life Sciences Group, Inc.
A late-stage clinical biopharmaceutical company focused on developing novel therapies for...
New York, United States
About Inventiva Pharma
Inventiva Pharma, founded in 2012 and headquartered in France, is a clinical-stage biopharmaceutical company specializing in developing oral small molecule therapies for critical unmet medical needs. Their research targets areas such as fibrosis, lysosomal storage disorders, and oncology, with specific programs focusin...
Development of oral small molecule therapies, Clinical trials and research programs, Drug candidate development for unmet medical needs
Patients with fibrosis, Patients with lysosomal storage disorders, Patients with oncology needs, Health care providers and researchers focusing on NASH and MPS
Biopharmaceutical, Clinical-stage, Oral Small Molecule Therapies, Fibrosis, Lysosomal Storage Disorders, Oncology, NASH (Nonalcoholic Steatohepatitis), MPS (Mucopolysaccharidoses), SSc (Systemic Sclerosis), Drug Discovery, Nuclear Receptors, Transcription Factors, Epigenetic Modulation, Proprietary Molecules, Research And Development
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Inventiva Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Inventiva Pharma on 18 Sep 2025. The 11 companies listed here were last checked between 13 Sep 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
